Latest News, Press Releases & Events

Spyryx Biosciences to Present at American Thoracic Society International Conference May 19- 24,2017, Washington, DC

Company to Detail Positive Data for SPX-101 for Cystic Fibrosis DURHAM, N.C., May 16, 2017 /PRNewswire/ — Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, today announced that it will present two abstracts highlighting the safety, pharmacokinetics and mechanism of action of SPX-101, the Company’s pipeline therapeutic treatment […]

Continue Reading

Spyryx Biosciences Partners with Cystic Fibrosis Canada, Serves as Presenting Sponsor of the 16th Broken Arrow Conference May 4-6, Toronto, Ontario

Company continues its outreach to the CF community in support of SPX-101’s Phase 2 clinical program DURHAM, N.C., May 4, 2017 – Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung disease, announced today that it will serve as the presenting sponsor of Cystic Fibrosis Canada’s 16th Broken Arrow Conference. […]

Continue Reading

Spyryx Biosciences to Present at the Needham Healthcare Conference

Spyryx Biosciences to Present at the Needham Healthcare Conference Tuesday, April 4, 2017 New York, NY Durham, North Carolina – March 29, 2017. Spyryx Biosciences, a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, announced today that John Taylor, President and CEO, will present at the Needham Healthcare Conference on Tuesday, April […]

Continue Reading